Clinical Trials Browser

Terminated × Brain Neoplasms × Imatinib Mesylate × Clear all

NCT00171938 2017-02-24

Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)

Phase 2 Terminated

Brain Neoplasms, Glioblastoma

NCT00585221 2017-02-10

Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients

Phase 2 Terminated

8 enrolled 4 charts

CNSGastrointestinalSarcoma

Brain Neoplasms, Gastrointestinal Stromal Tumors